entertainment -WSS

entertainment

author：fashion 2025-09-30 05:03:42 - browse：35561

health care AI border between health care and tech — Adobe

There’s been significant investment in companies creating artificial intelligence (AI) applications for health and health care over the last decade. But while there have been successes, notably in the area of medical imaging, the industry is known more for not yet living up to its potential — think IBM Watson.

The slow pace of AI adoption in health care stems from the fact that health AI sits on the border between two large industries, health care and tech. And like the border between two nations, there are significant differences on either side.

During my career, I have spent time on each side. Now, as the CEO of a company on the border, I’ve developed a deeper understanding of the differences that create barriers to mutual innovation. For health AI to achieve its potential, health care and tech companies must keep the big picture top of mind: health care is about saving lives.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： California wildfire smoke linked to 52,000 early deaths, study says

WSS

Pharma needs to include young adults in clinical research

NIH tests clinical research in primary care with $30 million program

Medical schools are missing the mark on artificial intelligence

Climate activists disrupt London Pride march to protest corporate sponsorship

Pharma companies must ensure equitable access to obesity drugs

Statins may not be needed by millions of people, study suggests

focus

entertainment

explore

Medicare details structure of new drug price negotiation program

Teen charged with murder as hate crime in killing of NYC dancer O'Shae Sibley: Sources

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Slain Parkland victim's father speaks out following reenactment

Alkermes shareholders re

Moderna says combo Covid

How one medical school became remarkably diverse

Teladoc has a new CEO, but challenges remain the same

Peter Hotez and the public health issue of online harassment

Lilly's Alzheimer's drug donanemab backed by FDA advisers

focus

Lifetime voting ban for felony convictions struck down in Mississippi

Medical device trials still don't enroll enough women, study finds

Does Medicare's free annual wellness visit do any good?

The system is set up to fail children with medical complexity

Flash flooding emergencies prompt evacuations in Kentucky, Tennessee

Teladoc has a new CEO, but challenges remain the same

explore

leisure time

focus

leisure time